Evidence map›Paper›PMID 27656679›Full record

ArticleNPJ breast cancer2015

αB-crystallin Expression in Breast Cancer is Associated with Brain Metastasis.

K David Voduc, Torsten O Nielsen, Charles M Perou, J Chuck Harrell, Cheng Fan, Hagen Kennecke, Andy J Minn, Vincent L Cryns, Maggie C U Cheang

Open access · goldAbstract read
In one paragraph

Article in NPJ breast cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Exploring the Therapeutic Potential ofAnti-cancer agents in medicinal chemistry · 2026
    Review
  3. Genomic and immune profiling of breast cancer brain metastases.Acta neuropathologica communications · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. The Proliferative and Apoptotic Landscape of Basal-like Breast Cancer.International journal of molecular sciences · 2019
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

K David VoducDepartment of Radiation Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada.
Torsten O NielsenDepartment of Pathology and Laboratory Medicine, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada.
Charles M PerouLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
J Chuck HarrellDepartment of Pathology, Virginia Commonwealth University, Richmond, VA, USA.
Cheng FanLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Hagen KenneckeDivision of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada.
Andy J MinnDepartment of Radiation Oncology, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA.
Vincent L Cryns *Department of Medicine, University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Maggie C U Cheang *Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
BC Cancer Agency · CAUniversity of North Carolina at Chapel Hill · USInstitute of Cancer Research · GBUniversity of British Columbia · CAUniversity of Pennsylvania · USUniversity of Wisconsin Carbone Cancer Center · USVirginia Commonwealth University · US

Funding

Tissue Procurement & PathologyP50CA058223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KATHERINE A. HOADLEY · 1992 to 2026
$59.3M
Cancer Research UK 15955Cancer Research UK A15955NCI NIH HHS P50 CA058223
6 · The paper itself

Abstract

BACKGROUND/

objectivesThe molecular chaperone αB-crystallin is expressed in estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 "triple-negative" breast carcinomas and promotes brain and lung metastasis. We examined αB-crystallin expression in primary breast carcinomas with metastatic data to evaluate its association with prognosis and site-specific metastases.

methodsαB-crystallin gene (

resultsIn the 855Met dataset, αB-crystallin gene (

conclusionsαB-crystallin is a promising biomarker to identify breast cancer patients at high risk for early relapse in the brain, independent of ER and HER2 status.

Indexed as

biomarkerbrainmetastasistissue microarraytriple-negative breast cancerαB-crystallin

Identifiers

PMID27656679
PMCPMC5027912
OpenAlexW2544829712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.